Becton Dickinson Pty Ltd v B. Braun Melsungen AG [2018] FCA 1692

Becton Dickinson Pty Ltd v B. Braun Melsungen AG [2018] FCA 1692

Properly construed, the relevant patent claims were not infringed by the BD device because required integers concerning the location and movement of the needle protective device, resilient movement, valve abutment, and multiple plunger elements were absent. Certain claims were invalid for lack of fair basis because the specifications did not provide a real and reasonably clear disclosure of a catheter insertion device in which the needle protective device need not be located within the catheter hub. Becton's inventive step challenge failed because the evidence did not establish that the Fresenius blood control mechanism formed part of the common general knowledge in Australia at the...

Jurisdiction
Australia
Judgment Date
09 November 2018
Procedural Posture
Patent Proceeding Concerning Unjustified Threats, Infringement, Validity and Revocation / Final Judgment After Hearing
Outcome
Originating application dismissed; Braun's amended notice of cross-claim dismissed; claims 14 and 26 of Australian Patent No 2012244163, claim 17 of Australian Patent No 2012244164, and claim 10 of Australian Patent No 2013201814 revoked; amended notice of further cross-claim otherwise dismissed; costs submissions...
Legal Topics
['catheter Insertion Device Patents' 'claim Construction' 'patent Infringement' 'priority Date' 'fair Basis' 'inventive Step' 'unjustified Threats' 'revocation']

Case Brief

Summary, issues, holding and outcome

More case intelligence is available

Unlock the full research layer for this judgment.

Full judgment text Downloadable case file Legal principles 1 Authorities cited 2 Party arguments 2 Amounts and remedies 1
Sign in to unlock

Procedural Posture

Patent Proceeding Concerning Unjustified Threats, Infringement, Validity and Revocation / Final Judgment After Hearing

  1. 1 ['Whether the BD device infringed the relevant claims of Australian Patent No 2012244163, Australian Patent No 2012244164 and Australian Patent No 2013201814.' 'How the disputed claim integers, including "needle protective device", the location and movement of that device, the valve, and the valve actuating elements, should be construed.' 'Whether the relevant claims were entitled to the asserted priority date based on matter disclosed in the Parent.' 'Whether the relevant claims were invalid for lack of fair basis under s 40(3) of the Patents Act 1990 (Cth).' 'Whether the relevant claims were invalid for lack of inventive step.' 'Whether Becton was entitled to relief for alleged unjustified threats under s 128 of the Patents Act 1990 (Cth).']

Ratio Decidendi

Properly construed, the relevant patent claims were not infringed by the BD device because required integers concerning the location and movement of the needle protective device, resilient movement, valve abutment, and multiple plunger elements were absent. Certain claims were invalid for lack of fair basis because the specifications did not provide a real and reasonably clear disclosure of a catheter insertion device in which the needle protective device need not be located within the catheter hub. Becton's inventive step challenge failed because the evidence did not establish that the Fresenius blood control mechanism formed part of the common general knowledge in Australia at the...

Court Disposition

Originating application dismissed; Braun's amended notice of cross-claim dismissed; claims 14 and 26 of Australian Patent No 2012244163, claim 17 of Australian Patent No 2012244164, and claim 10 of Australian Patent No 2013201814 revoked; amended notice of further cross-claim otherwise dismissed; costs submissions...

Orders

  • ['The originating application be dismissed.' 'The amended notice of cross-claim be dismissed.' 'Claims numbered 14 and 26 in Australian Patent No 2012244163 be revoked.' 'Claim numbered 17 in Australian Patent No 2012244164 be revoked.' 'Claim numbered 10 in Australian Patent No 2013201814 be revoked.' 'The amended...